| Log in

Bionpharma acquires 25 products of Banner Life Sciences

21 December, 2015

Bionpharma, a New Jersey-based pharmaceutical startup founded by former Ranbaxy executives, has bought 25 products from Banner Life Sciences, a division of US-based Patheon, The Economic Times reported.

The acquired products, which include cetirizine and ibuprofen and sold over the counter in the US, together generate revenues of $70 million.

Bionpharma was founded in November 2014 by five senior executives , including CEO Venkat Krishnan, of Ranbaxy Laboratories’ US arm. The company was formed to offer services for Indian and European drug makers seeking to enter the US.

Currently, New York-based global investment firm Signet Healthcare owns more than 40 per cent in Bionpharma. Canadian drugmaker Pharmascience is the second-largest equity holder while the five former Ranbaxy executives form the third-largest group of shareholders. 

The launch of Bionpharma came after India’s top drugmaker Sun Pharmaceutical Industries announced last year that it will acquire Ranbaxy Laboratories. The deal worth $3.2 billion was completed in March 2015.


Leave Your Comment
Sun Pharma to buy Ranbaxy in $3.2B all-stock deal

Sun Pharma to buy Ranbaxy in $3.2B all-stock deal

TEAM VCC 4 years ago
Sun Pharmaceutical Industries Ltd, the country’s top drugmaker by market cap,...
Company watch: Concord Biotech eyes new opportunities after Quadria’s backing

Company watch: Concord Biotech eyes new opportunities after Quadria’s backing

Jyotindra Dubey 10 months ago
Biotechnologist Sudhir Vaid quit drugmaker Ranbaxy Laboratories Ltd exactly 20...
Sun Pharma plans to acquire oral and injectable business to grow capacity

Sun Pharma plans to acquire oral and injectable business to grow capacity

TEAM VCC 5 years ago
Sun Pharmaceuticals Industries Ltd, Asia’s largest generic drugmaker by market...
No Comments

Bionpharma acquires 25 products of Banner Life Sciences

Powered by WordPress.com VIP